Drug Shortage Report for JALYN
| Report ID | 211335 |
| Drug Identification Number | 02372010 |
| Brand name | JALYN |
| Common or Proper name | dutasteride/tamsulosin hydrochloride modified release capsules |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE DUTASTERIDE |
| Strength(s) | 0.4MG 0.5MG |
| Dosage form(s) | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30s |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-11-23 |
| Estimated end date | 2024-05-09 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-17 |
| Company comments | Inventory on allocation to support demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2024-04-17 | French | Compare |
| v8 | 2024-04-17 | English | Compare |
| v7 | 2024-01-24 | French | Compare |
| v6 | 2024-01-24 | English | Compare |
| v5 | 2024-01-19 | French | Compare |
| v4 | 2024-01-19 | English | Compare |
| v3 | 2023-11-24 | English | Compare |
| v2 | 2023-11-23 | French | Compare |
| v1 | 2023-11-23 | English | Compare |
Showing 1 to 9 of 9